No Data
Express News | Dogwood Therapeutics Shares Are Trading Lower. The Company Announced Top Line Data From the Recently Completed BHC IMC-2 Long-COVID Study
Dogwood Therapeutics Reports Positive Results From IMC-2 Study on Long-COVID Related Fatigue and Sleep Disturbance
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
Express News | Dogwood Therapeutics, Inc. Announces Low Dose Imc-2 Treatment Reduces Long-Covid Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study
12 Health Care Stocks Moving In Monday's Pre-Market Session
Top Premarket Decliners
Jenna Ragan : looks interesting
$Stryve Foods (SNAX.US)$